|
|
Other links at Articles > Pharmacists |
| 4. |
Triple-Drug Combo Improves Breast Cancer Outcomes With Low Cardiotoxicity
|
|
|
The addition of trastuzumab (Herceptin) to epirubicin and cyclophosphamide as first-line therapy improves survival with low dose-limiting cardiotoxicity in women with human epidermal growth factor receptor (HER)-2 positive metastatic breast cancer, new research shows. Reuters Health Information
|
| 5. |
Atacicept Shows Promise as Rheumatoid Arthritis Treatment
|
|
|
Atacicept, a recombinant fusion protein that neutralizes the cytokine B lymphocyte stimulator, is well tolerated and shows trends toward clinical improvement in patients with rheumatoid arthritis (RA), according to a report in the January issue of Arthritis & Rheumatism. Reuters Health Information
|
|
|
